Skip to menu Skip to content Skip to footer
Dr

David Briskey

Email: 

Overview

Background

Dr David Briskey is a research fellow at the UQ School of Human Movement and Nutrition Sciences. His major areas of research have included gastrointestinal health, liver and kidney disease and clinical trials. Within these research topics David has focused on the effects of supplementations, gastrointestinal health and exercise trials on: body composition, absorption/bioavailability (including pharmacokinetics), exercise recovery, inflammation, intestinal permeability, oxidative stress and biochemistry analysis. Clinical trials conducted have included trials on: body composition, appetite control, GIT health, inflammation, CKD, exercise and macula health. To date David has completed pharmacokinetic trials on: vitamin B12, C, D & E, CoQ10, alpha lipoic acid, glutathione, curcumin, fish oil, lutein, saffron and palmitoylethanolamine

Availability

Dr David Briskey is:
Available for supervision

Qualifications

  • Postgraduate Diploma, The University of Queensland
  • Masters (Coursework) of Applied Science, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Research interests

  • Biochemistry

  • GIT function and health

  • Supplement delivery technology

Works

Search Professor David Briskey’s works on UQ eSpace

56 works between 2012 and 2024

1 - 20 of 56 works

2024

Journal Article

Effect of Palmitoylethanolamide Compared to a Placebo on the Gut Microbiome and Biochemistry in an Overweight Adult Population: A Randomised, Placebo Controlled, Double-Blind Study

Batacan, Romeo, Briskey, David, Bajagai, Yadav Sharma, Smith, Chelsie, Stanley, Dana and Rao, Amanda (2024). Effect of Palmitoylethanolamide Compared to a Placebo on the Gut Microbiome and Biochemistry in an Overweight Adult Population: A Randomised, Placebo Controlled, Double-Blind Study. Biomedicines, 12 (7) ARTN 1620, 1620. doi: 10.3390/biomedicines12071620

Effect of Palmitoylethanolamide Compared to a Placebo on the Gut Microbiome and Biochemistry in an Overweight Adult Population: A Randomised, Placebo Controlled, Double-Blind Study

2024

Journal Article

Comparison of the effects of Wild Nutrition Food‑Grown® vitamin D3 formulation with two conventional formulations on increasing plasma vitamin D levels in healthy participants: A 72‑h, randomised, parallel, comparator study

Briskey, David and Rao, Amanda (2024). Comparison of the effects of Wild Nutrition Food‑Grown® vitamin D3 formulation with two conventional formulations on increasing plasma vitamin D levels in healthy participants: A 72‑h, randomised, parallel, comparator study. International Journal of Functional Nutrition, 5 (1) 3. doi: 10.3892/ijfn.2024.37

Comparison of the effects of Wild Nutrition Food‑Grown® vitamin D3 formulation with two conventional formulations on increasing plasma vitamin D levels in healthy participants: A 72‑h, randomised, parallel, comparator study

2024

Journal Article

Newly developed dietary assessment tools for lutein and zeaxanthin are correlated with 24-hour diet recalls, but are not a valid measure of intake in Australian and United Kingdom adults

Fitzpatrick, Naomi Kathleen, Capra, Sandra, Shore, Angela, Briskey, David, Jackman, Sarah, Bowtell, Joanna and Chachay, Veronique (2024). Newly developed dietary assessment tools for lutein and zeaxanthin are correlated with 24-hour diet recalls, but are not a valid measure of intake in Australian and United Kingdom adults. Nutrition Research, 122, 68-79. doi: 10.1016/j.nutres.2023.12.010

Newly developed dietary assessment tools for lutein and zeaxanthin are correlated with 24-hour diet recalls, but are not a valid measure of intake in Australian and United Kingdom adults

2024

Journal Article

Effectiveness of palmitoylethanolamide (Levagen+) compared to a placebo for reducing pain, duration, and medication use during migraines in otherwise healthy participants—a double-blind randomised controlled study

Briskey, David, Skinner, Rachael, Smith, Chelsie and Rao, Amanda (2024). Effectiveness of palmitoylethanolamide (Levagen+) compared to a placebo for reducing pain, duration, and medication use during migraines in otherwise healthy participants—a double-blind randomised controlled study. Pharmaceuticals, 17 (2) 145. doi: 10.3390/ph17020145

Effectiveness of palmitoylethanolamide (Levagen+) compared to a placebo for reducing pain, duration, and medication use during migraines in otherwise healthy participants—a double-blind randomised controlled study

2024

Journal Article

A randomized double-blind trial to measure the absorption characteristics of eicosapentaenoic acid and docosahexaenoic acid rich oil blend with natural lipid-based delivery system

Chuang, Jennifer, Briskey, David, Dang, Jennifer, Rajgopal, Arun and Rao, Amanda (2024). A randomized double-blind trial to measure the absorption characteristics of eicosapentaenoic acid and docosahexaenoic acid rich oil blend with natural lipid-based delivery system. Food Science and Biotechnology, 33 (8), 1957-1964. doi: 10.1007/s10068-023-01466-z

A randomized double-blind trial to measure the absorption characteristics of eicosapentaenoic acid and docosahexaenoic acid rich oil blend with natural lipid-based delivery system

2023

Journal Article

The effect of Levagen+ (Palmitoylethanolamide) supplementation on symptoms of allergic rhinitis—a double-blind placebo-controlled trial

Briskey, David, Ebelt, Phillippa and Rao, Amanda (2023). The effect of Levagen+ (Palmitoylethanolamide) supplementation on symptoms of allergic rhinitis—a double-blind placebo-controlled trial. Nutrients, 15 (23) 4940. doi: 10.3390/nu15234940

The effect of Levagen+ (Palmitoylethanolamide) supplementation on symptoms of allergic rhinitis—a double-blind placebo-controlled trial

2023

Journal Article

The efficacy of palmitoylethanolamide (Levagen+) on the incidence and symptoms of upper respiratory tract infection—A double blind, randomised, placebo-controlled trial

Rao, Amanda, Skinner, Rachael and Briskey, David (2023). The efficacy of palmitoylethanolamide (Levagen+) on the incidence and symptoms of upper respiratory tract infection—A double blind, randomised, placebo-controlled trial. Nutrients, 15 (20) 4453, 1-9. doi: 10.3390/nu15204453

The efficacy of palmitoylethanolamide (Levagen+) on the incidence and symptoms of upper respiratory tract infection—A double blind, randomised, placebo-controlled trial

2023

Conference Publication

Modulating inflammation and immune function through the dietary nitrate-nitrite-nitric oxide pathway to promote vascular health: insights from a randomized, controlled study

Raubenheimer, Kyle, Hickey, Danica, Leveritt, Michael, Fassett, Robert, Ortiz de Zevallos Munoz, Joaquin, Allen, Jason D., Briskey, David, Parker, Tony J., Kerr, Graham, Peake, Jonathan M., Pecheniuk, Natalie M. and Neubauer, Oliver (2023). Modulating inflammation and immune function through the dietary nitrate-nitrite-nitric oxide pathway to promote vascular health: insights from a randomized, controlled study. Redox Biology Congress 202306-09, Vienna, Austria, June 2023. Philadelphia, PA USA: Elsevier. doi: 10.1016/j.freeradbiomed.2023.03.209

Modulating inflammation and immune function through the dietary nitrate-nitrite-nitric oxide pathway to promote vascular health: insights from a randomized, controlled study

2023

Other Outputs

Lutein and zeaxanthin dietary screeners validation study in healthy Australian and United Kingdom adults

Fitzpatrick, Naomi, Chachay, Veronique, Capra, Sandra, Jackman, S.R. and Briskey, David (2023). Lutein and zeaxanthin dietary screeners validation study in healthy Australian and United Kingdom adults. The University of Queensland. (Dataset) doi: 10.48610/f9416b1

Lutein and zeaxanthin dietary screeners validation study in healthy Australian and United Kingdom adults

2023

Journal Article

Efficacy of topical palmitoylethanolamide (Levagen+) for the management of eczema symptoms: a double-blind, comparator-controlled, randomized clinical trial

Rao, Amanda, Moussa, Amel A., Erickson, Jane and Briskey, David (2023). Efficacy of topical palmitoylethanolamide (Levagen+) for the management of eczema symptoms: a double-blind, comparator-controlled, randomized clinical trial. Skin Pharmacology and Physiology, 36 (6), 288-295. doi: 10.1159/000536670

Efficacy of topical palmitoylethanolamide (Levagen+) for the management of eczema symptoms: a double-blind, comparator-controlled, randomized clinical trial

2023

Other Outputs

Development and validity evaluation of an electronic device use questionnaire in Australian and United Kingdom adults

Fitzpatrick, Naomi, Chachay, Veronique, Capra, Sandra, S.R.Jackman and Briskey, David (2023). Development and validity evaluation of an electronic device use questionnaire in Australian and United Kingdom adults. The University of Queensland. (Dataset) doi: 10.48610/61b97b1

Development and validity evaluation of an electronic device use questionnaire in Australian and United Kingdom adults

2023

Journal Article

Efficacy of a Kiwifruit Extract (PhenActivTM) on Gastrointestinal Tract Function: A Randomised Double-Blind Placebo-Controlled Study

Briskey, David, Mallard, Alistair Rowan and Rao, Amanda (2023). Efficacy of a Kiwifruit Extract (PhenActivTM) on Gastrointestinal Tract Function: A Randomised Double-Blind Placebo-Controlled Study. Food and Nutrition Sciences, 14 (12), 1281-1295. doi: 10.4236/fns.2023.1412081

Efficacy of a Kiwifruit Extract (PhenActivTM) on Gastrointestinal Tract Function: A Randomised Double-Blind Placebo-Controlled Study

2022

Journal Article

A double-blind, randomised cross-over study to evaluate the absorption of a commercially available Ginkgo biloba extract compared to the liposomal extract Ginkgosome

Briskey, David and Rao, Amanda (2022). A double-blind, randomised cross-over study to evaluate the absorption of a commercially available Ginkgo biloba extract compared to the liposomal extract Ginkgosome. BMC Complementary Medicine and Therapies, 22 (1) 206, 1-6. doi: 10.1186/s12906-022-03679-x

A double-blind, randomised cross-over study to evaluate the absorption of a commercially available Ginkgo biloba extract compared to the liposomal extract Ginkgosome

2022

Journal Article

Effectiveness of “Moro” blood orange Citrus sinensis Osbeck (Rutaceae) standardized extract on weight loss in overweight but otherwise healthy men and women—a randomized double-blind placebo-controlled study

Briskey, David, Malfa, Giuseppe Antonio and Rao, Amanda (2022). Effectiveness of “Moro” blood orange Citrus sinensis Osbeck (Rutaceae) standardized extract on weight loss in overweight but otherwise healthy men and women—a randomized double-blind placebo-controlled study. Nutrients, 14 (3) 427, 427. doi: 10.3390/nu14030427

Effectiveness of “Moro” blood orange Citrus sinensis Osbeck (Rutaceae) standardized extract on weight loss in overweight but otherwise healthy men and women—a randomized double-blind placebo-controlled study

2022

Journal Article

The Effect of a Dispersible Curcumin (HydroCurc®) Compared to a Placebo for Reducing Joint Pain in an Adult Population - A Randomised, Double-Blind Study

Briskey, David, Roche, Georgia and Rao, Amanda (2022). The Effect of a Dispersible Curcumin (HydroCurc®) Compared to a Placebo for Reducing Joint Pain in an Adult Population - A Randomised, Double-Blind Study. Complementary Medicine Research, 29 (6), 429-436. doi: 10.1159/000524689

The Effect of a Dispersible Curcumin (HydroCurc®) Compared to a Placebo for Reducing Joint Pain in an Adult Population - A Randomised, Double-Blind Study

2021

Journal Article

Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study

Rao, Amanda, Ebelt, Phillippa, Mallard, Alistair and Briskey, David (2021). Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study. Sleep Science and Practice, 5 (1) 12, 12. doi: 10.1186/s41606-021-00065-3

Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study

2021

Journal Article

An appraisal of trials investigating the effects on macular pigment optical density of lutein and zeaxanthin dietary interventions: a narrative review

Fitzpatrick, Naomi, Chachay, Veronique, Bowtell, Joanna, Jackman, Sarah, Capra, Sandra, Shore, Angela and Briskey, David (2021). An appraisal of trials investigating the effects on macular pigment optical density of lutein and zeaxanthin dietary interventions: a narrative review. Nutrition Reviews, 80 (3), 513-524. doi: 10.1093/nutrit/nuab038

An appraisal of trials investigating the effects on macular pigment optical density of lutein and zeaxanthin dietary interventions: a narrative review

2021

Journal Article

The effect of an orally‐dosed Gynostemma pentaphyllum extract (ActivAMP®) on body composition in overweight, adult men and women: a double‐blind, randomised, placebo‐controlled study

Rao, Amanda, Clayton, Paul and Briskey, David (2021). The effect of an orally‐dosed Gynostemma pentaphyllum extract (ActivAMP®) on body composition in overweight, adult men and women: a double‐blind, randomised, placebo‐controlled study. Journal of Human Nutrition and Dietetics, 35 (3) jhn.12936, 583-589. doi: 10.1111/jhn.12936

The effect of an orally‐dosed Gynostemma pentaphyllum extract (ActivAMP®) on body composition in overweight, adult men and women: a double‐blind, randomised, placebo‐controlled study

2021

Journal Article

Iron depletion attenuates steatosis in a mouse model of non-alcoholic fatty liver disease: Role of iron-dependent pathways

Crawford, Darrell H.G., Ross, Diana G.F., Jaskowski, Lesley-Anne, Burke, Leslie J., Britton, Laurence J., Musgrave, Nick, Briskey, David, Rishi, Gautam, Bridle, Kim R. and Subramaniam, V. Nathan (2021). Iron depletion attenuates steatosis in a mouse model of non-alcoholic fatty liver disease: Role of iron-dependent pathways. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1867 (7) 166142, 166142. doi: 10.1016/j.bbadis.2021.166142

Iron depletion attenuates steatosis in a mouse model of non-alcoholic fatty liver disease: Role of iron-dependent pathways

2021

Journal Article

Short duration alagebrium chloride therapy prediabetes does not inhibit progression to autoimmune diabetes in an experimental model

Borg, Danielle J., Faridi, Pouya, Giam, Kai Lin, Reeves, Peta, Fotheringham, Amelia K., McCarthy, Domenica A., Leung, Sherman, Ward, Micheal S., Harcourt, Brooke E., Ayala, Rochelle, Scheijen, Jean L., Briskey, David, Dudek, Nadine L., Schalkwijk, Casper G., Steptoe, Raymond, Purcell, Anthony W. and Forbes, Josephine M. (2021). Short duration alagebrium chloride therapy prediabetes does not inhibit progression to autoimmune diabetes in an experimental model. Metabolites, 11 (7) 426, 1-21. doi: 10.3390/metabo11070426

Short duration alagebrium chloride therapy prediabetes does not inhibit progression to autoimmune diabetes in an experimental model

Funding

Current funding

  • 2016 - 2024
    Postdoctoral Fellowship in Nutrition Physiology and Biochemistry
    RDC Global Pty Ltd
    Open grant

Past funding

  • 2016 - 2017
    Resistive Breathing and Respiratory Muscle Induced Oxidative Stress (Internal Grant administered by University of Southern Queensland)
    University of Southern Queensland
    Open grant

Supervision

Availability

Dr David Briskey is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Dr David Briskey's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au